Cohort study shows increased risk of post-COVID-19 condition in those with penicillin allergy labels, suggesting important implications.
Summary Penicillin allergy labelling was associated with increased risk of post‐COVID‐19 condition and subsequent clinical outcomes. The increased risk of subsequent clinical outcomes was not mediated by PCC.
No takes yet. Share an insight, caveat, or question.
Chaichana et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: